Tradestie Institutional Equity Comparison Engine

XNCR vs XENE โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

XNCR Overall Edge

XNCR Captures Institutional Edge (3โ€“1 Pillars ยท 5โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Xencor, Inc. (XNCR) driven by superior Valuation, Momentum & Technical, Options & Structure while XENE counters with relative strength in Growth & Margin. Fundamentally, XNCR trades at 68.0x Forward P/E with -72.7% operating margin (+454.9% YoY revenue) versus XENE at N/M Forward P/E and 0.0% operating margin (-100.0% YoY). In options structure, XNCR sits in BREAKOUT (10th %ile IV; Dealer Gamma Walls on Pro) against XENE sits in BREAKDOWN (14th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner XNCR
XNCR 68.0x vs XENE N/M Fwd P/E
Growth & Margin Winner XENE
Op Margin -72.7% vs 0.0% ยท YoY +454.9% vs -100.0%
Momentum & Technical Winner XNCR
1Y +154.5% vs -1.8% ยท 52W Pos 84% vs 15%
Options & Structure Winner XNCR
BREAKOUT (10th %ile IV) vs BREAKDOWN (14th %ile IV)
XNCR NASDAQ
Xencor, Inc.
Pharmaceutical Preparations
$35.61
-3.99% 1D
Market Cap $2.9B
1M Return +55.84%
1Y Return +154.54%
Forward P/E 68.0x
Unified AI Score
29.6 / 100 SELL
Tech 50.0 Fund 32.0 Flow 66.0 Mom 40.0
XENE NASDAQ
Xenon Pharmaceuticals Inc
Pharmaceutical Preparations
$39.30
-2.9% 1D
Market Cap $4.0B
1M Return +17.36%
1Y Return -1.84%
Forward P/E N/M
Unified AI Score
33.3 / 100 SELL
Tech 15.0 Fund 44.0 Flow 68.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: XNCR +154.54% XENE -1.84% Spread: +156.38 pp (XNCR Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period XNCR Revenue XENE Revenue XNCR Op. Margin XENE Op. Margin Margin Edge
FY2018 $40M N/A -195.5% N/A XNCR
FY2019 $160M $10M 8.8% -627.0% XNCR
FY2020 $120M $30M -62.6% -97.3% XNCR
FY2021 $280M $20M 15.9% -428.4% XNCR
FY2022 $160M $10M -50.1% -1368.9% XNCR
FY2023 $170M N/A -75.8% N/A XNCR
FY2024 $110M N/A -161.5% N/A XNCR
FY2025 $130M $10M -141.4% -4974.3% XNCR

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: XNCR (5) vs XENE (5)
Institutional Metric XNCR XENE Criterion Row Winner
Market Capitalization Scale $2.9B $4.0B Larger Scale XENE
Trailing P/E Ratio Valuation 68.0x N/M Lower Multiple XNCR
Forward P/E Ratio Valuation 68.0x N/M Lower Multiple XNCR
Revenue Growth (YoY) Growth +454.9% -100.0% Higher Growth XNCR
Operating Margin (TTM) Profitability -72.7% 0.0% Higher Margin XENE
Net Profit Margin Profitability -58.8% 0.0% Higher Margin XENE
Return on Equity (ROE) Capital Efficiency -19.9% -50.3% Higher ROE XNCR
52-Week Range Position Momentum 84% ($10โ€“$41) 15% ($33โ€“$73) Stronger Trend XNCR
Beta / 30D Volatility Risk Regime 1.21ฮฒ ยท 87% Vol 0.70ฮฒ ยท 36% Vol Lower Realized Risk XENE
Unified Institutional Score Composite Signal 29.6 / 100 (SELL) 33.3 / 100 (SELL) Higher Composite XENE

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full XNCR vs XENE Buy Guide
XNCR BREAKOUT
58d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 10th %ile
IV Regime Compressed (<25th %ile)
Live XNCR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
XENE BREAKDOWN
175d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 14th %ile
IV Regime Compressed (<25th %ile)
Live XENE Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither XNCR nor XENE registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.